Literature DB >> 9667956

Novel and specific respiratory syncytial virus inhibitors that target virus fusion.

W D Ding1, B Mitsner, G Krishnamurthy, A Aulabaugh, C D Hess, J Zaccardi, M Cutler, B Feld, A Gazumyan, Y Raifeld, A Nikitenko, S A Lang, Y Gluzman, B O'Hara, G A Ellestad.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9667956     DOI： 10.1021/jm980239e

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  12 in total

Review 1.  Protein recognition using synthetic surface-targeted agents.

Authors:  Rishi Jain; Justin T Ernst; Olaf Kutzki; Hyung Soon Park; Andrew D Hamilton
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

2.  Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion.

Authors:  Christopher Cianci; David R Langley; Douglas D Dischino; Yaxiong Sun; Kuo-Long Yu; Anne Stanley; Julia Roach; Zhufang Li; Richard Dalterio; Richard Colonno; Nicholas A Meanwell; Mark Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-06       Impact factor: 11.205

Review 3.  Knitting and untying the protein network: modulation of protein ensembles as a therapeutic strategy.

Authors:  Susana Gordo; Ernest Giralt
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

4.  Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors.

Authors:  Xiufang Zheng; Lisha Wang; Baoxia Wang; Kun Miao; Kunlun Xiang; Song Feng; Lu Gao; Hong C Shen; Hongying Yun
Journal:  ACS Med Chem Lett       Date:  2016-04-20       Impact factor: 4.345

Review 5.  Targeting RSV with vaccines and small molecule drugs.

Authors:  Heather M Costello; William C Ray; Supranee Chaiwatpongsakorn; Mark E Peeples
Journal:  Infect Disord Drug Targets       Date:  2012-04

6.  Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors.

Authors:  Xiufang Zheng; Chungen Liang; Lisha Wang; Kun Miao; Baoxia Wang; Weixing Zhang; Dongdong Chen; Guolong Wu; Wei Zhu; Lei Guo; Song Feng; Lu Gao; Hong C Shen; Hongying Yun
Journal:  Medchemcomm       Date:  2019-05-06       Impact factor: 3.597

7.  RFI-641, a potent respiratory syncytial virus inhibitor.

Authors:  Clayton C Huntley; William J Weiss; Anna Gazumyan; Aron Buklan; Boris Feld; William Hu; Thomas R Jones; Timothy Murphy; Antonia A Nikitenko; Bryan O'Hara; Gregory Prince; Susan Quartuccio; Yuri E Raifeld; Philip Wyde; John F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Dendrimers Based on [1,3,5]-Triazines.

Authors:  Mackay B Steffensen; Emily Hollink; Frank Kuschel; Monika Bauer; Eric E Simanek
Journal:  J Polym Sci A Polym Chem       Date:  2006-06-01       Impact factor: 2.702

9.  (S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.

Authors:  Blake P Moore; Dong Hoon Chung; Daljit S Matharu; Jennifer E Golden; Clinton Maddox; Lynn Rasmussen; James W Noah; Melinda I Sosa; Subramaniam Ananthan; Nichole A Tower; E Lucile White; Fuli Jia; Thomas E Prisinzano; Jeffrey Aubé; Colleen B Jonsson; William E Severson
Journal:  J Med Chem       Date:  2012-10-16       Impact factor: 7.446

10.  Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection.

Authors:  Christopher Cianci; Eugene V Genovesi; Lucinda Lamb; Ivette Medina; Zheng Yang; Lisa Zadjura; Hyekyung Yang; Celia D'Arienzo; Ny Sin; Kuo-Long Yu; Keith Combrink; Zhufang Li; Richard Colonno; Nicholas Meanwell; Junius Clark; Mark Krystal
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.